stopped for 9 months and the fullness went within a fortnight of the last dose
#cagrilintide 2025-04-17
- VialBot — Testing queue: 8 submissions open, 92 awaiting dispatch. 17:07
- VialBot — On this day 3 years ago this channel logged 86 messages. 19:11
- salt_bridge — nobody should copy my schedule, im describing it because people asked what a slow ramp looks like 19:31
- salt_bridge — monotherapy question, did appetite move for you without a GLP-1 alongside 19:40
anyone dosing this on a different day to their semaglutide
went slower because the first step gave me two rough days and i took that as information
titrating dead slow
CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it
held mine a while
how slow are people titrating this compared to tirzepatide
2 in 1.5ml gives 2.5mg/ml which is what i use, purely because the units come out round
did the combination change your GI compared to the GLP-1 alone
*VendorInvestigate not the other one
if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way
Testing queue: 8 submissions open, 92 awaiting dispatch.
how many weeks before you noticed anything on monotherapy
combination for me
back after 1 months, is monotherapy still a minority thing here
how do people separate which of the two is doing what in a combination
amylin analogue, so its not a GLP-1 at all right
is anyone running this on its own or is it all CagriSema in here
the nausea felt different rather than less, more fullness and less of the queasy wave
whats the recon people use, 30 in 2.5ml
the fullness thing is the part people describe differently, food stops being interesting rather than repellent
the combination is the thing with trial data behind it, monotherapy in here is mostly us guessing
thats the phase 3 one
anyone holding at 12 for a while before stepping
On this day 3 years ago this channel logged 86 messages.
did the nausea feel different to you or just less
dropped the GLP-1 and stayed on this alone for 3 months, appetite held but weight barely moved
does amylin do something about fullness that the GLP-1 doesnt
amylin not glp-1
fullness rather than nausea
underwhelming honestly
nobody should copy my schedule, im describing it because people asked what a slow ramp looks like
combination GI was worse than either alone for me, which is not what i had read anywhere, anyway
is the nausea profile genuinely different or am i imagining it
REDEFINE is the phase 3 programme, most of what gets quoted casually in here is earlier work
i keep the two on separate days so if something goes wrong i have a chance of knowing which
*Janoshik not the other one
monotherapy question, did appetite move for you without a GLP-1 alongside
is 2.4 the number for this too or am i confusing compounds
*Medutest not the other one